Count | |
| 13 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Phosphatidylcholines/antagonists & inhibitors/*biosynthesis/metabolism | 1 |
| 5 | |
| 34 | |
| 1 | |
| 11 | |
| 1 | |
| 1 | |
| 91 | |
| 22 | |
| 2 | |
| 14 | |
| 1 | |
| 2 | |
| 20 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 19 | |
| 1 | |
| 15 | |
| 1 | |
| 50 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 4 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Phosphatidylcholines/*administration & dosage/therapeutic use | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Phosphatidylcholines/administration & dosage/blood/*pharmacology | 1 |
Phosphatidylcholines/*administration & dosage/adverse effects | 1 |
| 11 | |
| 91 | |
| 1 | |
| 2 | |
| 584 | |
| 1 | |
| 100 | |
| 1 | |
| 3 | |
| 43 | |
| 2 | |
| 1 | |
| 18 | |
| 43 | |
| 4 | |
| 6 | |
| 1 | |
| 1 | |
| 10 | |
| 1 | |
| 16 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 52 | |
| 2 | |
| 10 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 1 | |